| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241950 | Respiratory Medicine | 2014 | 34 Pages |
Abstract
An MI-protective effect of tiotropium compared to placebo was found, which might be attributable to an effective COPD treatment leading to a decrease in COPD-related cardiovascular events. Further studies with effective control arms and minimal CV risk are required determining precisely tiotropium's cardiovascular risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Marietta Rottenkolber, Dominik Rottenkolber, Rainald Fischer, Luisa Ibáñez, Joan Fortuny, Elena Ballarin, Monica Sabaté, Pili Ferrer, Petra Thürmann, Joerg Hasford, Sven Schmiedl,